India
· Delayed Price · Currency is INR Concord Biotech Company Description
Concord Biotech Limited, a biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally.
The company provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas.
It also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, voclosporin, and pimecrolimus for immunosuppressants therapeutic segment; and temsirolimus, everolimus, romidepsin, doxorubicin, mitomycin, midostaurin, and dactinomycin for oncology therapeutic segment.
In addition, the company provides mupirocin, mupirocin calcium, polymyxin B sulfate, fidaxomicin, vancomycin hydrochloride, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi, micafungin sodium, and nystatin for anti-fungal therapeutic segment; and lovastatin and pravastatin sodium for other applications.
Further, it develops daptomycin for anti-infectives applications; and epirubicin, idarubicin, and pirarubicin for oncology therapeutic segment.
Additionally, the company provides contract research and manufacturing services in the areas of fermentation and semi-synthesis products.
Concord Biotech Limited was incorporated in 1984 and is based in Ahmedabad, India.
| Country | India |
| Founded | 1984 |
| Industry | Pharmaceutical Preparations |
| Employees | 1,571 |
Contact Details
Address: 16th Floor, B-Wing Ahmedabad, Gujarat 380015 India | |
| Phone | 91 79 6813 8700 |
| Website | concordbiotech.com |
Stock Details
| Ticker Symbol | 543960 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |